Fotios Loupakis

8PUBLICATIONS
49CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.

Somaieh Hedayat, Luciano Cascione, David Cunningham

|May 20, 2020
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.

Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti

|Apr 10, 2020
Investigating the concordance in molecular subtypes of primary colorectal tumors and their matched synchronous liver metastasis.

Andreas Schlicker, Architha Ellappalayam, Ines J Beumer

|Jan 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.

Fotios Loupakis, Ilaria Depetris, Paola Biason

|Nov 10, 2019
Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status.

Fotios Loupakis, Giulia Maddalena, Ilaria Depetris

|Jun 26, 2019
Claudin-18 expression in oesophagogastric adenocarcinomas: a tissue microarray study of 523 molecularly profiled cases.

Irene Coati, Gábor Lotz, Giuseppe Nicolò Fanelli

Pageof 2

Frequent Collaborators

2 joint publications

Marta Schirripa

2 joint publications

Filippo Pietrantonio

1 joint publications

Ryuma Tokunaga

1 joint publications

Sebastian Stintzing